Rivista
/
/
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
JoVE Journal
Genetica
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Genetica
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
DOI:

08:22 min

March 12, 2018

, , , , ,

Capitoli

  • 00:04Titolo
  • 00:54sgRNA Surveyor Nuclease Assay
  • 02:50Cas9 mRNA Production
  • 04:11sgRNA Production
  • 05:30Embryo Collection, Microinjection, and In Vitro Culture
  • 06:43Results: Superior Integration with Cas9
  • 07:46Conclusion

Summary

Traduzione automatica

The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) system provides a promising tool for genetic engineering, and opens up the possibility of targeted integration of transgenes. We describe a homology-mediated end joining (HMEJ)-based strategy for efficient DNA targeted integration in vivo and targeted gene therapies using CRISPR/Cas9.

Video correlati

Read Article